CLINICAL_TRIALS
research
· 2026-04-15
Clinical Trial Update: A Study of HRS-2129 in Patients With Diabetic Peripheral Neuropathic Pain [Phase 1]
Summary
A Phase 1 study of HRS-2129 for diabetic peripheral neuropathy is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shandong Suncadia Medicine Co., Ltd. | Conditions: Diabetic Peripheral Neuropathic Pain | Phase 1 | Status: RECRUITING